Free Trial

Intuitive Surgical, Inc. (NASDAQ:ISRG) Short Interest Update

Intuitive Surgical logo with Medical background

Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) was the recipient of a significant decrease in short interest in the month of November. As of November 30th, there was short interest totalling 3,460,000 shares, a decrease of 16.6% from the November 15th total of 4,150,000 shares. Based on an average daily trading volume, of 1,250,000 shares, the days-to-cover ratio is currently 2.8 days.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the sale, the chief executive officer now directly owns 24,219 shares in the company, valued at approximately $12,391,166.97. The trade was a 42.84 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction that occurred on Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total value of $58,542.48. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company's stock, valued at $4,746,819.42. This trade represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 48,190 shares of company stock valued at $25,012,927. 0.90% of the stock is currently owned by company insiders.

Institutional Trading of Intuitive Surgical

Several large investors have recently made changes to their positions in the company. Ridgewood Investments LLC bought a new stake in Intuitive Surgical during the second quarter worth $26,000. Godsey & Gibb Inc. lifted its position in shares of Intuitive Surgical by 140.0% during the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after buying an additional 35 shares during the last quarter. LGT Financial Advisors LLC boosted its stake in Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock valued at $30,000 after buying an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in Intuitive Surgical in the third quarter valued at about $33,000. Finally, Mark Sheptoff Financial Planning LLC acquired a new position in Intuitive Surgical during the second quarter worth about $37,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Stock Down 0.9 %

Shares of ISRG traded down $5.14 during trading hours on Friday, hitting $539.58. 1,071,762 shares of the company were exchanged, compared to its average volume of 1,439,538. Intuitive Surgical has a fifty-two week low of $320.26 and a fifty-two week high of $556.23. The company has a market cap of $192.19 billion, a price-to-earnings ratio of 86.75, a P/E/G ratio of 5.35 and a beta of 1.38. The firm's fifty day moving average is $521.82 and its 200 day moving average is $478.46.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last announced its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts anticipate that Intuitive Surgical will post 5.45 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of research analysts recently weighed in on ISRG shares. Citigroup boosted their target price on Intuitive Surgical from $567.00 to $640.00 and gave the stock a "buy" rating in a report on Wednesday. Raymond James increased their price objective on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an "outperform" rating in a research report on Monday, October 14th. Wells Fargo & Company lifted their target price on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an "overweight" rating in a report on Wednesday. Piper Sandler restated an "overweight" rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Mizuho boosted their price objective on Intuitive Surgical from $440.00 to $500.00 in a report on Thursday, October 17th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have given a buy rating to the stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average price target of $550.28.

Read Our Latest Analysis on ISRG

Intuitive Surgical Company Profile

(Get Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Should you invest $1,000 in Intuitive Surgical right now?

Before you consider Intuitive Surgical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.

While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines